Ballentine Partners’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding QGEN
Ballentine Partners's QGEN Position: Q4 2025 in Review
Ballentine Partners sold out of Qiagen (QGEN) in Q4 2025, closing a stake of 4,939 shares — an estimated $220K sold.
Ballentine Partners first reported a position in QGEN in Q4 2024 and held it in 3 quarters. The position peaked at $241K in Q4 2024. 321 funds tracked by Wall St. Rank hold QGEN as of Q4 2025.
- Ballentine Partners reported no remaining Qiagen position as of Q4 2025 after selling out during the quarter.
- Ballentine Partners sold 4,939 Qiagen shares in Q4 2025, an estimated $220K.
- Ballentine Partners first reported a position in Qiagen in Q4 2024 and held it in 3 quarters.
- Ballentine Partners's Qiagen position peaked at $241K in Q4 2024.
- 321 funds tracked by Wall St. Rank held Qiagen as of Q4 2025.
Based on Ballentine Partners's 13F filing for Q4 2025, filed 3 Feb 2026.